BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 31672299)

  • 1. Molecular Imaging and Therapy of Differentiated Thyroid Carcinoma in Adults.
    Mulugeta PG; Chi AW; Anderson TM
    Cancer J; 2024 May-Jun 01; 30(3):194-201. PubMed ID: 38753754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of COVID-19 pandemic restrictions on the management of differentiated thyroid cancer in Turkey: a single tertiary centre experience.
    Calapkulu M; Sencar ME; Ozturk Unsal I; Sakiz D; Tekinyildiz M; Ozbek M; Cakal E
    Eur Arch Otorhinolaryngol; 2024 May; 281(5):2587-2595. PubMed ID: 38347198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Invasive Differentiated Thyroid Cancer.
    Nixon IJ; Simo R; Newbold K; Rinaldo A; Suarez C; Kowalski LP; Silver C; Shah JP; Ferlito A
    Thyroid; 2016 Sep; 26(9):1156-66. PubMed ID: 27480110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current approach to pediatric differentiated thyroid cancer.
    Ozgen Kiratli P; Volkan-Salanci B
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):32-39. PubMed ID: 38445831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Approaches to Thyroid Cancer Treatment and Response Assessment.
    Grewal RK; Ho A; Schöder H
    Semin Nucl Med; 2016 Mar; 46(2):109-18. PubMed ID: 26897715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid cancer surgery guidelines in an era of de-escalation.
    Kovatch KJ; Hoban CW; Shuman AG
    Eur J Surg Oncol; 2018 Mar; 44(3):297-306. PubMed ID: 28385370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid cancer: burden of illness and management of disease.
    Brown RL; de Souza JA; Cohen EE
    J Cancer; 2011 Apr; 2():193-9. PubMed ID: 21509149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Surveillance and Conversion Surgery for Low-Risk Thyroid Cancer-The Disconnect Between Literature and Practice.
    Ho AS; Davies L; Yeh MW
    JAMA Otolaryngol Head Neck Surg; 2024 May; ():. PubMed ID: 38749063
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in Stage Distribution and Disease-Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta-Analysis.
    Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
    Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine.
    Matrone A; Campopiano MC; Nervo A; Sapuppo G; Tavarelli M; De Leo S
    Front Endocrinol (Lausanne); 2019; 10():884. PubMed ID: 31998228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of qualitative and quantitative parameters of contrast-enhanced ultrasound for differentiating differentiated thyroid carcinomas from benign nodules.
    Fan J; Tao L; Zhan W; Li W; Kuang L; Zhao Y; Zhou W
    Front Endocrinol (Lausanne); 2023; 14():1240615. PubMed ID: 38250738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.
    Lechner MG; Brent GA
    Clin Cancer Res; 2024 Apr; 30(7):1220-1222. PubMed ID: 38197869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study).
    Ming J; Zhu JQ; Zhang H; Sun H; Wang J; Cheng RC; Xie L; Li XR; Tian W; Huang T
    BMC Endocr Disord; 2021 Oct; 21(1):208. PubMed ID: 34670546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis.
    Toraih EA; Fawzy MS; Hussein MH; El-Labban MM; Ruiz EML; Attia AA; Halat S; Moroz K; Errami Y; Zerfaoui M; Kandil E
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Low-Risk Thyroid Cancers: Is Active Surveillance a Valid Option? A Systematic Review of the Literature.
    Patrone R; Velotti N; Masone S; Conzo A; Flagiello L; Cacciatore C; Filardo M; Granata V; Izzo F; Testa D; Avenia S; Sanguinetti A; Polistena A; Conzo G
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total thyroidectomy
    Barbaro D; Basili G; Materazzi G
    Gland Surg; 2021 Jul; 10(7):2275-2283. PubMed ID: 34422598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in the treatment of differentiated thyroid cancer.
    Stewart LA; Kuo JH
    Ther Adv Endocrinol Metab; 2021; 12():20420188211000251. PubMed ID: 33796254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Differentiated Thyroid Carcinomas.
    Lechner MG; Praw SS; Angell TE
    Surg Pathol Clin; 2019 Dec; 12(4):931-942. PubMed ID: 31672299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.